新型冠状病毒肺炎潜在治疗药物研究进展  

Research progresses of potential therapeutic drugs for novel coronavirus pneumonia

作　　者：周廉政 张明顺[2,3] 吉宁飞 黄茂 ZHOU Lianzheng;ZHANG Mingshun;JI Ningfei;HUANG Mao(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029;Key Laboratory of Antibody Techniques,National Health Commission,Nanjing 211166,China;Department of Immunology,Nanjing Medical University,Nanjing 211166,China)

机构地区：[1]南京医科大学第一附属医院呼吸与危重症医学科,江苏南京210029 [2]南京医科大学国家卫生健康委员会抗体技术重点实验室,江苏南京211166 [3]南京医科大学免疫学系,江苏南京211166

出　　处：《南京医科大学学报（自然科学版）》2020年第3期315-321,366,共8页Journal of Nanjing Medical University(Natural Sciences)

基　　金：国家自然科学基金面上项目(81970031,81770031);江苏省自然科学基金面上项目(BK20181497,BK20171501);新型冠状病毒肺炎疫情防控科技应急攻关第二批项目(BE2020616)。

摘　　要：自2019年12月以来,新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情已蔓延至全国各地及部分国外地区。截至2020年2月21日,全国累计确诊人数已超7万。抗病毒药物方面,目前仍没有确认有效的药物。药物治疗已成为当前的热点话题,现结合我国已注册开展的COVID-19临床研究,将潜在有效的治疗药物及相关研究作一介绍,供临床参考和借鉴,以期临床早日用上有效药,从而提高治愈率,降低病死率,控制疫情的发展。Since December 2019,the novel coronavirus pneumonia(coronavirus disease 2019,COVID-19)has spread to all provinces of China and some other regions abroad.As of February 21,2020,the total number of confirmed cases in China has exceeded 70000.In terms of antiviral drugs,there are still no confirmed effective drugs against COVID-19.The present study aims to introduce the potential effective drugs and related research progress,providing helpful information for improving the cure rate,reducing the mortality and controlling the development of the epidemic.

关 键 词：新型冠状病毒肺炎 COVID-19 治疗药物 临床试验 

分 类 号：R512.99[医药卫生—内科学]